Study Recommends New Treatment Target for Glioblastoma Multiforme

University of Texas (UT) Southwestern Medical Center researchers have published the results of a study in the online journal Nature that reveals why the most common, deadly brain tumor in adults recurs and identifies a possible target for future therapies.

Glioblastoma multiforme (GBM) is a fast-growing, malignant brain tumor that occurred in 15 percent of the estimated 22,000 Americans diagnosed with brain and nervous system tumors in 2010. Although it responds to initial therapy, the cancer almost always returns and currently is considered incurable. The median survival rate is about 15 months, National Cancer Institute reports. For more information, click here to read the full release.